Immunotherapy-related adverse events in real-world patients with advanced non-small cell lung cancer on chemoimmunotherapy: a Spinnaker study sub-analysis

BACKGROUND: The Spinnaker study evaluated survival outcomes and prognostic factors in patients with advanced non-small-cell lung cancer receiving first-line chemoimmunotherapy in the real world. This sub-analysis assessed the immunotherapy-related adverse effects (irAEs) seen in this cohort, their i...

Descripción completa

Detalles Bibliográficos
Autores principales: Anpalakhan, Shobana, Huddar, Prerana, Behrouzi, Roya, Signori, Alessio, Cave, Judith, Comins, Charles, Cortellini, Alessio, Addeo, Alfredo, Escriu, Carles, McKenzie, Hayley, Barone, Gloria, Murray, Lisa, Pinato, David J., Ottensmeier, Christian, Campos, Sara, Muthuramalingam, Sethupathi, Chan, Samuel, Gomes, Fabio, Banna, Giuseppe L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10265987/
https://www.ncbi.nlm.nih.gov/pubmed/37324003
http://dx.doi.org/10.3389/fonc.2023.1163768

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10265987/
https://www.ncbi.nlm.nih.gov/pubmed/37324003
http://dx.doi.org/10.3389/fonc.2023.1163768

Ejemplares similares